MicroRNA-143 (miR-143) Regulates Cancer Glycolysis via Targeting Hexokinase 2 Gene
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
High glycolysis, well known as "Warburg effect," is frequently observed in a variety of cancers. Whether the deregulation of miRNAs contributes to the Warburg effect remains largely unknown. Because miRNA regulates gene expression at both mRNA and protein levels, we constructed a gene functional association network, which allows us to detect the gene activity instead of gene expression, to integratively analyze the microarray data for gene expression and miRNA expression profiling and identify glycolysis-related gene-miRNA pairs deregulated in cancer. Hexokinase 2 ( HK2 ), coding for the first rate-limiting enzyme of glycolysis, is among the top list of genes predicted and potentially regulated by multiple miRNAs including miR-143. Interestingly, miR-143 expression was inversely associated with HK2 protein level but not mRNA level in human lung cancer samples. miR-143, down-regulated by mammalian target of rapamycin activation, reduces glucose metabolism and inhibits cancer cell proliferation and tumor formation through targeting HK2 . Collectively, we have not only established a novel methodology for gene-miRNA pair prediction but also identified miR-143 as an essential regulator of cancer glycolysis via targeting HK2 . Background: Hexokinase 2 ( HK2 ) is frequently overexpressed in malignant tumors. Results: miR-143 down-regulates HK2 and inhibits glucose metabolism and cancer progression. Conclusion: miR-143 is an essential regulator of cancer glycolysis via targeting HK2 . Significance: Discovering the important role of miRNA in cancer metabolism may provide potential targets for cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425 · cited 1×
“The “Warburg effect” described the unique metabolic phenomenon that conversion of glucose into lactic acid is enhanced even in the presence of oxygen (1, 2).”
BackgroundExploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603
Bolstad, B. M., Irizarry, R. A., Åstrand, M., & Speed, T. P. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.2.185 · Cited by 8,266
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1997 · Cited by 7,590
Summaries of Affymetrix GeneChip probe level data
Irizarry, R. A. (2003) · Nucleic Acids Research · doi:10.1093/nar/gng015 · Cited by 4,887
Mammalian microRNAs predominantly act to decrease target mRNA levels
Guo, H., Ingolia, N. T., Weissman, J. S., & Bartel, D. P. (2010) · Nature · doi:10.1038/nature09267 · Cited by 3,886 · cited 2×
“miRNAs play critical regulatory roles in diverse biological processes including metabolism (10, 11) and tumorigenesis (12, 13).”
BackgroundMethodMicroRNA Targeting Specificity in Mammals: Determinants beyond Seed Pairing
Grimson, A., Farh, K. K.-H., Johnston, W. K., Garrett-Engele, P., Lim, L. P., & Bartel, D. P. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.06.017 · Cited by 3,766
Widespread changes in protein synthesis induced by microRNAs
Selbach, M., Schwanhäusser, B., Thierfelder, N., Fang, Z., Khanin, R., & Rajewsky, N. (2008) · Nature · doi:10.1038/nature07228 · Cited by 3,429 · cited 1×
“Because miRNA regulates target genes at both the mRNA and the protein levels (12, 27, 29, 30), traditional methods simply using gene expression value for genemiRNA pair prediction may fail to pick up those genes with mainly protein level changes.”
MethodSelf-citationThe Versatile Role of microRNA-30a in Human Cancer
Wang, C., Yang, X., Chen, Y., & Chen, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000471111 · Cited by 3,409
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
Yanaihara, N., Caplen, N., Bowman, E., Seike, M., Kumamoto, K., Yi, M., Stephens, R. M., Okamoto, A., Yokota, J., Tanaka, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.01.025 · Cited by 3,023
Bushati, N., & Cohen, S. M. (2007) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.23.090506.123406 · Cited by 2,750
Cancer cell metabolism: warburg and beyond
Hsu, P. P., & Sabatini, D. M. (2008) · Cell · doi:10.1016/j.cell.2008.08.021 · Cited by 2,452
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124 · cited 1×
“miRNAs play critical regulatory roles in diverse biological processes including metabolism (10, 11) and tumorigenesis (12, 13).”
Backgroundlet-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells
Yu, F., Yao, H., Zhu, P., Zhang, X., Pan, Q., Gong, C., Huang, Y., Hu, X., Su, F., Lieberman, J., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.054 · Cited by 1,910
Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data
Dai, M. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni179 · Cited by 1,797
The tor pathway: a target for cancer therapy
Bjornsti, M.-A., & Houghton, P. J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1362 · Cited by 1,314
MiR-33 Contributes to the Regulation of Cholesterol Homeostasis
Rayner, K. J., Suárez, Y., Dávalos, A., Parathath, S., Fitzgerald, M. L., Tamehiro, N., Fisher, E. A., Moore, K. J., & Fernández-Hernando, C. (2010) · Science · doi:10.1126/science.1189862 · Cited by 1,260
Somatic activation of the K-ras oncogene causes early onset lung cancer in mice
Johnson, L., Mercer, K., Greenbaum, D., Bronson, R. T., Crowley, D., Tuveson, D. A., & Jacks, T. (2001) · Nature · doi:10.1038/35074129 · Cited by 1,179
Repression of protein synthesis by miRNAs: how many mechanisms?
Pillai, R. S., Bhattacharyya, S. N., & Filipowicz, W. (2007) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.12.007 · Cited by 1,108
Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function
Wilson, J. E. (2003) · Journal of Experimental Biology · doi:10.1242/jeb.00241 · Cited by 1,085 · cited 1×
“There are four important mammalian hexokinase isozymes designated HK1–4 that vary in subcellular locations and kinetics with respect to different substrates and conditions and physiological functions (6).”
BackgroundWolf, A., Agnihotri, S., Micallef, J., Mukherjee, J., Sabha, N., Cairns, R., Hawkins, C., & Guha, A. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101470 · Cited by 789 · cited 1×
“At this location, HK2 helps couple ATP formation in mitochondria to the phosphorylation of glucose, thus conferring cancer cells with a highly glycolytic phenotype and ample biosynthetic precursor (2, 8).”
BackgroundMathupala, S. P., Ko, Y. H., & Pedersen, P. L. (2006) · Oncogene · doi:10.1038/sj.onc.1209603 · Cited by 765
Landi, M. T., Dracheva, T., Rotunno, M., Figueroa, J. D., Liu, H., Dasgupta, A., Mann, F. E., Fukuoka, J., Hames, M., Bergen, A. W., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001651 · Cited by 680
Real-time PCR quantification of precursor and mature microRNA
Schmittgen, T. D., Lee, E. J., Jiang, J., Sarkar, A., Yang, L., Elton, T. S., & Chen, C. (2008) · Methods · doi:10.1016/j.ymeth.2007.09.006 · Cited by 616
Mathupala, S. P., Ko, Y. H., & Pedersen, P. L. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.11.006 · Cited by 574
An expanding role for mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.06.007 · Cited by 523
Roles of p53, MYC and HIF-1 in regulating glycolysis–the seventh hallmark of cancer
Yeung, S. J., Pan, J., & Lee, M.-H. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8224-x · Cited by 514
A Parsimonious Model for Gene Regulation by miRNAs
Djuranovic, S., Nahvi, A., & Green, R. (2011) · Science · doi:10.1126/science.1191138 · Cited by 469
Pedersen, P. L. (2007) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-007-9094-x · Cited by 425
Pedersen, P. L., Mathupala, S., Rempel, A., Geschwind, J. F., & Ko, Y. H. (2002) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(02)00248-7 · Cited by 356
Jiang, S., Zhang, L., Zhang, H., Hu, S., Lu, M., Liang, S., Li, B., Li, Y., Li, D., Wang, E., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.45 · Cited by 356
Su, L.-J., Chang, C.-W., Wu, Y.-C., Chen, K.-C., Lin, C.-J., Liang, S.-C., Lin, C.-H., Whang-Peng, J., Hsu, S.-L., Chen, C.-H., et al. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-140 · Cited by 340
Li, D., Shimamura, T., Ji, H., Chen, L., Haringsma, H. J., McNamara, K., Liang, M.-C., Perera, S. A., Zaghlul, S., Borgman, C. L., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.06.005 · Cited by 238
Self-citationMammalian target of rapamycin regulates miRNA-1 and follistatin in skeletal myogenesis
Sun, Y., Ge, Y., Drnevich, J., Zhao, Y., Band, M., & Chen, J. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200912093 · Cited by 192
Self-citationmiR-143 regulates hexokinase 2 expression in cancer cells
Peschiaroli, A., Giacobbe, A., Formosa, A., Markert, E. K., Bongiorno-Borbone, L., Levine, A. J., Candi, E., D'Alessandro, A., Zolla, L., Finazzi Agrò, A., et al. (2013) · Oncogene · doi:10.1038/onc.2012.100 · Cited by 177
A network-based gene-weighting approach for pathway analysis
Fang, Z., Tian, W., & Ji, H. (2011) · Cell Research · doi:10.1038/cr.2011.149 · Cited by 56
Self-citation
Cited by
Bu, D., Luo, H., Huo, P., Wang, Z., Zhang, S., He, Z., Wu, Y., Zhao, L., Liu, J., Guo, J., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab447 · Cited by 1,885
MicroRNAome genome: A treasure for cancer diagnosis and therapy
Berindan‐Neagoe, I., Monroig, P. D. C., Pasculli, B., & Calin, G. A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21244 · Cited by 522
Roberts, D. J., & Miyamoto, S. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.173 · Cited by 504
MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance
Iqbal, M. A., Arora, S., Prakasam, G., Calin, G. A., & Syed, M. A. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.07.003 · Cited by 449
Review of aerobic glycolysis and its key enzymes – new targets for lung cancer therapy
Li, X., Gu, J., & Zhou, Q. (2015) · Thoracic Cancer · doi:10.1111/1759-7714.12148 · Cited by 331
Metadata
- Authors
- Fang, R., Xiao, T., Fang, Z., Sun, Y., Li, F., Gao, Y., Feng, Y., Li, L., Wang, Y., Liu, X., Chen, H., Liu, X.-Y., & Ji, H.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2012-06
- Volume
- 287
- Issue
- 27
- Pages
- 23227-23235
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2035310028
- Cited by
- 253
- References
- 36
- FWCI
- 6.03
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.